Brief: 111 Inc Enters Into Agreement With Zelgen
03/08/2021 13:14
Aug 3 (Reuters) - Suzhou Zelgen Biopharmaceuticals Co Ltd
688266.SS :
* 111, INC. ENTERS INTO STRATEGIC COOPERATION AGREEMENT WITH
ZELGEN TO DEVELOP A NEW MANAGEMENT PLATFORM FOR LIVER CANCER
PATIENTS IN CHINA
Source text for Eikon: ID:nPn9KyTCsa
Further company coverage: 688266.SS
((Reuters.Briefs@thomsonreuters.com;))